Hazard score predicts risk for onset of prostate cancer
Scientists have developed a hazard score to predict the onset of aggressive prostate cancer.
The hope is that it will be used to decide who and when to screen and contribute to successful treatment.
Many guidelines do not endorse universal screening due to concerns over elevated levels of prostate specific antigen (PSA) in men without cancer and over-treatment of men who have cancer without it becoming aggressive.
The researchers, led by scientists at the University of California, used data from a multinational consortium investigating prostate cancer, called Practical , to develop and test the genetic tool to predict age of onset of aggressive prostate cancer.
After analysing over 200,000 gene variants from 31,747 men of European ancestry with and without prostate cancer, the researchers identified 54 associated...
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests